Anti-PD-L1 antibodies
Abstract:
Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and methods of using such antibodies to restore T-cell function in T-cells exhibiting T-cell exhaustion or T-cell anergy.
Public/Granted literature
Information query
Patent Agency Ranking
0/0